Spahn-Langguth H

References (2)

Title : Rate-limiting biotransformation of triamterene is mediated by CYP1A2 - Fuhr_2005_Int.J.Clin.Pharmacol.Ther_43_327
Author(s) : Fuhr U , Kober S , Zaigler M , Mutschler E , Spahn-Langguth H
Ref : Int J Clinical Pharmacology & Therapeutics , 43 :327 , 2005
Abstract : Fuhr_2005_Int.J.Clin.Pharmacol.Ther_43_327
ESTHER : Fuhr_2005_Int.J.Clin.Pharmacol.Ther_43_327
PubMedSearch : Fuhr_2005_Int.J.Clin.Pharmacol.Ther_43_327
PubMedID: 16035375

Title : The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure - Soldner_1996_Pharmazie_51_783
Author(s) : Soldner A , Spahn-Langguth H , Mutschler E
Ref : Pharmazie , 51 :783 , 1996
Abstract : Soldner_1996_Pharmazie_51_783
ESTHER : Soldner_1996_Pharmazie_51_783
PubMedSearch : Soldner_1996_Pharmazie_51_783
PubMedID: 8985974